Treatment, Medication & Supplement Directory
A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.
Named profile Palladia (Toceranib): Approved Canine Mast Cell Tumor Targeted TherapyRepresentative category illustration – no product packaging is shown.Palladia (Toceranib): Approved Canine Mast Cell Tumor Targeted Therapy
Palladia is an FDA-approved prescription veterinary tyrosine kinase inhibitor for treatment of Patnaik grade II or III recurrent canine cutaneous mast cell tumors, with or without regional lymph-node…
Read moreNamed profile Laverdia (Verdinexor): FDA-Approved Oral Therapy for Canine LymphomaRepresentative category illustration – no product packaging is shown.Laverdia (Verdinexor): FDA-Approved Oral Therapy for Canine Lymphoma
Verdinexor is an oral prescription antineoplastic for certain dogs with lymphoma. FDA announced full approval in January 2026 after the product's earlier conditional-approval pathway; publication should use the…
Read more
CHOP-Style Chemotherapy for Canine Lymphoma: Protocol Discussion Profile
CHOP is a family of veterinary lymphoma protocols built around cyclophosphamide, hydroxydaunorubicin (doxorubicin), vincristine and prednisone. Exact sequence, dose and duration vary by oncology service and patient.
Read more
Carboplatin in Veterinary Oncology: Infusion, Monitoring, and Safety Profile
Carboplatin is a platinum-based cytotoxic chemotherapy drug used by veterinary oncologists for selected canine and feline cancers. Its use in companion animals is veterinarian-directed and generally extra-label; it…
Read moreDoxorubicin in Veterinary Oncology: Infusion and Cumulative-Risk Profile
Doxorubicin is an anthracycline cytotoxic chemotherapy drug used by veterinary oncologists for lymphoma and several sarcomas and carcinomas. Companion-animal use is veterinarian-directed and generally extra-label, with drug-specific infusion…
Read more
Lomustine (CCNU) in Veterinary Oncology: Delayed-Toxicity Safety Profile
Lomustine, also called CCNU, is an oral nitrosourea chemotherapy drug used by veterinary oncologists for selected cancers. Use in dogs and cats is generally extra-label and requires a…
Read more
Cancer Surgery: Biopsy, Excision, and Margin Planning
Surgery may obtain a diagnosis, remove a localized tumor, relieve obstruction or pain, or reduce complications. The first operation can determine later options, so biopsy route, intended margins,…
Read more
CT and MRI: Cross-Sectional Imaging for Tumor Decisions
CT and MRI create cross-sectional datasets that can map tumors beyond what is visible or palpable. CT uses x-rays and is fast and strong for many chest, bone,…
Read more
Antiemetic Support During Canine Cancer Treatment
Antiemetic therapy aims to prevent or control nausea and vomiting from chemotherapy, radiation fields, anesthesia, medications, the tumor, or another disease. Drug choice and timing depend on the…
Read moreComplete Blood Count Monitoring During Cancer Care
A CBC measures red cells, white cells, and platelets and is used to place symptoms and treatment safety in context; it does not by itself diagnose most tumors.
Read moreCoagulation Testing Before Biopsy, Surgery, or Invasive Care
Coagulation testing is selected when history, examination, disease, medication, or a planned procedure raises a bleeding or clotting question.
Read moreRegional Lymph Node Sampling for Cancer Staging
Lymph node size and feel are unreliable on their own, so selected nodes may be sampled when metastatic status would change a treatment plan.
Read more